MIF production of lymphocytes from patients with rheumatoid arthritis with antigen-antibody complexes.
AUTOR(ES)
Eibl, M M
RESUMO
Immune complexes, human erythrocytes coated with human IgG antibody, inhibit the migration of lymphocytes from rheumatoid arthritis (RA) patients. No correlation could be observed between migration inhibition and Waaler-Rose titre (sheep cell agglutination titre) in inidvidual patients. Production of migration inhibitory factor (MIF) could be detected in 16 of 20 cultures of RA lymphocytes incubated with antigen-antibody complexes, when the supernates were tested with guinea pig macrophages. Only two supernates of healthy persons showed migration inhibition activity under these conditions. The results suggest that migration inhibition by antigen antibody complexes in RA represents a true reaction of delayed hypersensitivity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1006358Documentos Relacionados
- Passive sensitization of lymphocytes and macrophages by antigen-antibody complexes.
- Platelet aggregation by hepatitis B surface antigen-antibody complexes.
- Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.
- Interaction of the Rheumatoid Factor with Antigen-Antibody Complexes and Aggregated Gamma Globulin
- Determination of human immunoglobulin M rheumatoid factor by a solid-phase radioimmunoassay which uses human immunoglobulin G in antigen-antibody complexes.
